Drug Pipeline

Valproic Acid Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
4
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-16 NCT01552434
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in…		 Trial terminated
2026-05-16 NCT01552434
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in…		 date change Primary completion moved earlier: 2026-10-31 -> 2026-05-08
2026-05-16 NCT01552434
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in…		 date change Completion moved earlier: 2026-10-31 -> 2026-05-08
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06929273 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in… Bipolar Disorder Type I With Mania Recruiting
Phase 2
NCT05821556 Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated… Adenocarcinoma of the Pancreas Recruiting
NCT02068586 Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk… Ciliary Body and Choroid Melanoma, Medium/Large Size Active, Not Recruiting
Phase 1/2
NCT03919292 Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca Solid Tumor, Adult Recruiting
Sponsors Running Valproic Acid Trials
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) Virginia Commonwealth University (1) National Cancer Institute, Naples (1) Bristol-Myers Squibb (1)
Disease Areas
Melanoma (1) Bipolar Disorder (1)
Get alerts when Valproic Acid trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free